For a change in the air monitoring sampling plan
Device | DUROLANE |
Generic Name | Acid, Hyaluronic, Intraarticular |
Applicant | Bioventus LLC |
Date Received | 2021-04-28 |
Decision Date | 2021-05-25 |
PMA | P170007 |
Supplement | S009 |
Product Code | MOZ |
Advisory Committee | Orthopedic |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | Bioventus LLC 4721 Emperor Blvd, Suite 100 durham, NC 27703 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P170007 | | Original Filing |
S014 |
2022-09-14 |
30-day Notice |
S013 |
2022-02-03 |
30-day Notice |
S012 |
2022-02-03 |
30-day Notice |
S011 |
2022-01-06 |
30-day Notice |
S010 |
2021-08-04 |
30-day Notice |
S009 |
2021-04-28 |
30-day Notice |
S008 |
2020-09-23 |
30-day Notice |
S007 |
2020-09-01 |
Normal 180 Day Track |
S006 |
2020-04-29 |
Real-time Process |
S005 |
2019-11-18 |
30-day Notice |
S004 |
2019-08-20 |
30-day Notice |
S003 |
2019-05-09 |
30-day Notice |
S002 |
2019-02-06 |
30-day Notice |
S001 |
2018-07-19 |
30-day Notice |
NIH GUDID Devices